Mediators of Inflammation · 2014 · 41 citations · 25 references
MedicinePharmacologyPharmacotherapyImmunopathologyInflammationPulmonologyAirway DiseasesAirway ImagingAnti-inflammatory PharmacologyCystic FibrosisPulmonary InflammationAirway Effects Of ExpansionAirway Inflammation ControlAirway Inflammation CorrelatesAirway Inflammation ImagingAirway Inflammation ModulationImmune MarkersOpen-label TrialsType Iv Collagen
BACKGROUND: Noncystic fibrosis bronchiectasis (NCFB) is characterized by airway expansion and recurrent acute exacerbations. Macrolide has been shown to exhibit anti-inflammatory effects in some chronic airway diseases. OBJECTIVE: To assess the efficacy of roxithromycin on airway inflammation and remodeling in patients with NCFB under steady state. METHODS: The study involved an open-label design in 52 eligible Chinese patients with NCFB, who were assigned to control (receiving no treatment) and roxithromycin (receiving 150 mg/day for 6 months) groups. At baseline and 6 months, the inflammatory markers such as interleukin- (IL-)8, neutrophil elastase (NE), matrix metalloproteinase- (MMP)9, hyaluronidase (HA), and type IV collagen in sputum were measured, along with the detection of dilated bronchus by throat computed tomography scan, and assessed the exacerbation. RESULTS: Forty-three patients completed the study. The neutrophil in the sputum was decreased in roxithromycin group compared with control (P < 0.05). IL-8, NE, MMP-9, HA, and type IV collagen in sputum were also decreased in roxithromycin group compared with the control group (all P < 0.01). Airway thickness of dilated bronchus and exacerbation were reduced in roxithromycin group compared with the control (all P < 0.05). CONCLUSIONS: Roxithromycin can reduce airway inflammation and airway thickness of dilated bronchus in patients with NCFB.
25
The St George's Respiratory Questionnaire
Paul Jones, Frances Quirk, Chloë M. Baveystock · Respiratory Medicine · 1991 · 2.7K citations · Full text
Emílio Pizzichini, Márcia Margaret Menezes Pizzichini, Ann Efthimiadis et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 977 citations
Surbhi Malhotra‐Kumar, Christine Lammens, Samuel Coenen et al. · The Lancet · 2007 · 553 citations
Pharmacy, Microbiology, Pharmacology +17